SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. P. Firdous, Girija Kuttan, Ramadasan Kuttan, Anti-inflammatory potential of carotenoidmeso-zeaxanthin and its mode of action, Pharmaceutical Biology, 2015, 1

    CrossRef

  2. 2
    Vikram D. Kekatpure, Mandeep Singh, Sumithra Selvam, Girish Shetkar, Naveen C. Hedne, Nirav P. Trivedi, Gangotri Siddappa, Sindhu V. Govindan, Amritha Suresh, Bharath Rangarajan, Andrew J. Dannenberg, Moni Abraham. Kuriakose, Factors predicting outcome after salvage treatment for stage IV oral squamous cell carcinoma: Evidence of the potential importance of the cyclooxygenase-2–prostaglandin E2 pathway, Head & Neck, 2015, 37, 4
  3. 3
    Maie A. St. John, Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma, The Laryngoscope, 2015, 125,
  4. 4
    K.-M. Fang, C.-S. Yang, T.-C. Lin, T.-C. Chan, S.-F. Tzeng, Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells, Neuro-Oncology, 2014, 16, 4, 552

    CrossRef

  5. 5
    Yu Du, Noah D. Peyser, Jennifer R. Grandis, Integration of molecular targeted therapy with radiation in head and neck cancer, Pharmacology & Therapeutics, 2014, 142, 1, 88

    CrossRef

  6. 6
    Fatih Celenk, Ismet Bayramoglu, Akin Yilmaz, Adnan Menevse, Yildirim Bayazit, Expression of Cyclooxygenase-2, 12-Lipoxygenase, and Inducible Nitric Oxide Synthase in Head and Neck Squamous Cell Carcinoma, Journal of Craniofacial Surgery, 2013, 24, 4, 1114

    CrossRef

  7. 7
    Annelies W Turksma, Boudewijn JM Braakhuis, Elisabeth Bloemena, Chris JLM Meijer, C René Leemans, Erik Hooijberg, Immunotherapy for head and neck cancer patients: shifting the balance, Immunotherapy, 2013, 5, 1, 49

    CrossRef

  8. 8
    Bit-Na Yoon, Kyong-Myong Chon, Sung-Lyong Hong, Jung-Hoon Lee, Jee-Yeon Kim, Kyu-Sup Cho, Hwan-Jung Roh, Inflammation and apoptosis in malignant transformation of sinonasal inverted papilloma: the role of the bridge molecules, cyclooxygenase-2, and nuclear factor κB, American Journal of Otolaryngology, 2013, 34, 1, 22

    CrossRef

  9. 9
    V. Patil, V. Noronha, V. Krishna, A. Joshi, K. Prabhash, Oral Metronomic Chemotherapy in Recurrent, Metastatic and Locally Advanced Head and Neck Cancers, Clinical Oncology, 2013, 25, 6, 388

    CrossRef

  10. 10
    Muneyuki Masuda, Satoshi Toh, Takahiro Wakasaki, Masumi Suzui, Andrew K. Joe, Somatic evolution of head and neck cancer – Biological robustness and latent vulnerability, Molecular Oncology, 2013, 7, 1, 14

    CrossRef

  11. 11
    Paulette Tamashiro, Hideki Furuya, Yoshiko Shimizu, Kayoko Iino, Toshihiko Kawamori, The Impact of Sphingosine Kinase-1 in Head and Neck Cancer, Biomolecules, 2013, 3, 3, 481

    CrossRef

  12. 12
    R.M. Abdel Hay, M.M. Fawzy, D. Metwally, D. Kadry, M. Ezzat, W. Rashwan, L.A. Rashed, DNA polymorphisms and tissue cyclooxygenase-2 expression in oral lichen planus: a case-control study, Journal of the European Academy of Dermatology and Venereology, 2012, 26, 9
  13. 13
    William N. William, Oral premalignant lesions, Current Opinion in Oncology, 2012, 24, 3, 205

    CrossRef

  14. 14
    Abie H. Mendelsohn, Chi K. Lai, I. Peter Shintaku, Michael C. Fishbein, Katherine Brugman, David A. Elashoff, Elliot Abemayor, Steven M. Dubinett, Maie A. St. John, Snail as a novel marker for regional metastasis in head and neck squamous cell carcinoma, American Journal of Otolaryngology, 2012, 33, 1, 6

    CrossRef

  15. 15
    Joseph J. Wakshlag, Jeanine Peters-Kennedy, Jennifer J. Bushey, John P. Loftus, 5-Lipoxygenase expression and tepoxalin-induced cell death in squamous cell carcinomas in cats, American Journal of Veterinary Research, 2011, 72, 10, 1369

    CrossRef

  16. 16
    Rui Amaral Mendes, João F.C. Carvalho, Isaac van der Waal, A comparative immunohistochemical analysis of COX-2, p53, and Ki-67 expression in keratocystic odontogenic tumors, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2011, 111, 3, 333

    CrossRef

  17. 17
    Vonetta M Williams, Maria Filippova, Ubaldo Soto, Penelope J Duerksen-Hughes, HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress, Future Virology, 2011, 6, 1, 45

    CrossRef

  18. 18
    Jessica C. Wilson, Lesley A. Anderson, Liam J. Murray, Carmel M. Hughes, Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review, Cancer Causes & Control, 2011, 22, 5, 803

    CrossRef

  19. 19
    Magdalena Halamka, Jakub Cvek, Jiri Kubes, Eva Zavadova, Pavel Kominek, Jaroslav Horacek, Ladislav Dusek, David Feltl, Plasma levels of vascular endothelial growth factor during and after radiotherapy in combination with celecoxib in patients with advanced head and neck cancer, Oral Oncology, 2011, 47, 8, 763

    CrossRef

  20. 20
    Rui Amaral Mendes, João F. C. Carvalho, Isaac van der Waal, Potential relevance of cyclooxygenase-2 expression in keratocystic odontogenic tumours – an immunohistochemical study, Journal of Oral Pathology & Medicine, 2011, 40, 6
  21. 21
    Tamaki Yamada, Masumi Tsuda, Tomomi Takahashi, Yasunori Totsuka, Masanobu Shindoh, Yusuke Ohba, RANKL Expression Specifically Observed in Vivo Promotes Epithelial Mesenchymal Transition and Tumor Progression, The American Journal of Pathology, 2011, 178, 6, 2845

    CrossRef

  22. 22
    Mohammad Aminur Rahman, A. R. M. Ruhul Amin, Dong M. Shin, Chemopreventive Potential of Natural Compounds in Head and Neck Cancer, Nutrition and Cancer, 2010, 62, 7, 973

    CrossRef

  23. 23
    Anthony Prince, Julio Aguirre-Ghizo, Eric Genden, Marshall Posner, Andrew Sikora, Head and Neck Squamous Cell Carcinoma: New Translational Therapies, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010, 77, 6
  24. 24
    Sittichai Koontongkaew, Paopanga Monthanapisut, Theeranuch Saensuk, Inhibition of arachidonic acid metabolism decreases tumor cell invasion and matrix metalloproteinase expression, Prostaglandins & Other Lipid Mediators, 2010, 93, 3-4, 100

    CrossRef

  25. 25
    Steven Chang, Patrick Ha, Cummings Otolaryngology - Head and Neck Surgery, 2010,

    CrossRef

  26. 26
    Rui Amaral Mendes, João F.C. Carvalho, Isaac van der Waal, An overview on the expression of cyclooxygenase-2 in tumors of the head and neck, Oral Oncology, 2009, 45, 10, e124

    CrossRef

  27. 27
    Camilla Husvik, Magne Bryne, Trond S. Halstensen, c-Jun N-terminal kinase negatively regulates epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines, European Journal of Oral Sciences, 2009, 117, 6
  28. 28
    Frederick Wang, Pattatheyil Arun, Jay Friedman, Zhong Chen, Carter Van Waes, Current and potential inflammation targeted therapies in head and neck cancer, Current Opinion in Pharmacology, 2009, 9, 4, 389

    CrossRef

  29. 29
    Heiko Neuss, Wieland Raue, Verena Müller, Wilko Weichert, Wolfgang Schwenk, Julian W. Mall, Effects of cyclooxygenase inhibition on anastomotic healing following large bowel resection in a rabbit model—a randomized, blinded, placebo-controlled trial, International Journal of Colorectal Disease, 2009, 24, 5, 551

    CrossRef

  30. 30
    Smita Agarwal, Gorla Venkateswara Reddy, Pallu Reddanna, Eicosanoids in inflammation and cancer: the role of COX-2, Expert Review of Clinical Immunology, 2009, 5, 2, 145

    CrossRef

  31. 31
    Yubin Hao, Tianpei Xie, Alexandru Korotcov, Yanfei Zhou, Xiaowu Pang, Liang Shan, Hongguang Ji, Rajagopalan Sridhar, Paul Wang, Joseph Califano, Xinbin Gu, Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivovia cyclooxygenase-2 and apoptotic pathways, International Journal of Cancer, 2009, 124, 9
  32. 32
    Cornelia Czembirek, Christina Eder-Czembirek, Boban M. Erovic, Dritan Turhani, Andreas Spittler, Edgar Selzer, Richard Pötter, Dietmar Thurnher, The Cyclooxygenase-2 Inhibitor Nimesulide, a Nonsteroidal Analgesic, Decreases the Effect of Radiation Therapy in Head-and-Neck Cancer Cells, Strahlentherapie und Onkologie, 2009, 185, 5, 310

    CrossRef

  33. 33
    Andreas Dietz, Andreas Boehm, Christian Mozet, Gunnar Wichmann, Athanassios Giannis, Current aspects of targeted therapy in head and neck tumors, European Archives of Oto-Rhino-Laryngology, 2008, 265, S1, 3

    CrossRef

  34. 34
    Pinar Ç. Özdal, Sonia Callejo, Amanda L. Caissie, Chaim Edelstein, Silvin Bakalian, Raul N. G. Vianna, Miguel N. Burnier, Cyclooxygenase-2 expression in human irradiated uveal melanomas, International Ophthalmology, 2008, 28, 1, 1

    CrossRef

  35. 35
    Pol M Specenier, Jan B Vermorken, Recurrent head and neck cancer: current treatment and future prospects, Expert Review of Anticancer Therapy, 2008, 8, 3, 375

    CrossRef

  36. 36
    B. M. Erovic, M. Woegerbauer, J. Pammer, E. Selzer, M. Ch. Grasl, D. Thurnher, Strong evidence for up-regulation of cyclooxygenase-1 in head and neck cancer, European Journal of Clinical Investigation, 2008, 38, 1
  37. 37
    A. Hayes, Cancer, cyclo-oxygenase and nonsteroidal anti-inflammatory drugs – can we combine all three?, Veterinary and Comparative Oncology, 2007, 5, 1
  38. 38
    John M Wrangle, Fadlo R Khuri, Chemoprevention of squamous cell carcinoma of the head and neck, Current Opinion in Oncology, 2007, 19, 3, 180

    CrossRef

  39. 39
    Alessandro Federico, Floriana Morgillo, Concetta Tuccillo, Fortunato Ciardiello, Carmela Loguercio, Chronic inflammation and oxidative stress in human carcinogenesis, International Journal of Cancer, 2007, 121, 11
  40. 40
    Evelyn Neppelberg, Anne Christine Johannessen, DNA content, Cyclooxygenase-2 expression and loss of E-cadherin expression do not predict risk of malignant transformation in oral lichen planus, European Archives of Oto-Rhino-Laryngology, 2007, 264, 10, 1223

    CrossRef

  41. 41
    Robert T. Dorsam, J. Silvio Gutkind, G-protein-coupled receptors and cancer, Nature Reviews Cancer, 2007, 7, 2, 79

    CrossRef

  42. 42
    Mark A. Scheper, Nikolaos G. Nikitakis, Risa Chaisuparat, Silvia Montaner, John J. Sauk, Sulindac Induces Apoptosis and Inhibits Tumor Growth In Vivo in Head and Neck Squamous Cell Carcinoma, Neoplasia, 2007, 9, 3, 192

    CrossRef

  43. 43
    Pol M. Specenier, Jan B. Vermorken, Targeted therapies in head and neck cancer, Targeted Oncology, 2007, 2, 2, 73

    CrossRef

  44. 44
    Alison Hayes, Treating cancer with NSAIDs. Reality or optimism?: Part 1, Companion Animal, 2007, 12, 8
  45. 45
    Sen-Tien Tsai, Kai-Ying Yang, Ying-Tai Jin, Yen-Chun Lin, Mei-Tzu Chang, Li-Wha Wu, Amphiregulin as a tumor promoter for oral squamous cell carcinoma: Involvement of cyclooxygenase 2, Oral Oncology, 2006, 42, 4, 381

    CrossRef

  46. 46
    Ingeborg Heirman, Daisy Ginneberge, Regina Brigelius-Flohé, Nico Hendrickx, Patrizia Agostinis, Peter Brouckaert, Pieter Rottiers, Johan Grooten, Blocking tumor cell eicosanoid synthesis by GPx4 impedes tumor growth and malignancy, Free Radical Biology and Medicine, 2006, 40, 2, 285

    CrossRef

  47. 47
    A. Hayes, T. Scase, J. Miller, S. Murphy, A. Sparkes, V. Adams, COX-1 and COX-2 Expression in Feline Oral Squamous Cell Carcinoma, Journal of Comparative Pathology, 2006, 135, 2-3, 93

    CrossRef

  48. 48
    ShouWei Han, Jesse Roman, COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signals, Lung Cancer, 2006, 51, 3, 283

    CrossRef

  49. 49
    Masashi Kakiuchi, Hidetsugu Tsujigiwa, Yorihisa Orita, Hitoshi Nagatsuka, Junko Yoshinobu, Shin Kariya, Shin-Ichi Haginomori, Saeko Orita, Kunihiro Fukushima, Mitsuhiro Okano, Noriyuki Nagai, Kazunori Nishizaki, Cyclooxygenase 2 expression in otitis media with effusion, American Journal of Otolaryngology, 2006, 27, 2, 81

    CrossRef

  50. 50
    Hong-ying Ruan, Muneyuki Masuda, Aya Ito, Kazuo Umezawa, Torahiko Nakashima, Ryuji Yasumatsu, Yuichiro Kuratomi, Tomoya Yamamoto, I. Bernard Weinstein, Shizuo Komune, Effects of a novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on growth, apoptosis, gene expression, and chemosensitivity in head and neck squamous cell carcinoma cell lines, Head & Neck, 2006, 28, 2
  51. 51
    Jing Wang, Fuping Guo, Hongyu Wei, Jijun Dong, Junzheng Wu, Expression of urokinase-type plasminogen activator receptor is correlated with metastases of lingual squamous cell carcinoma, British Journal of Oral and Maxillofacial Surgery, 2006, 44, 6, 515

    CrossRef

  52. 52
    S. H. Tannehill-Gregg, A. L. Levine, T. J. Rosol, Feline head and neck squamous cell carcinoma: a natural model for the human disease and development of a mouse model, Veterinary and Comparative Oncology, 2006, 4, 2
  53. 53
    Young Chang Lim, Seong-Ho Lee, Mee Hyun Song, Kiyoshi Yamaguchi, Joo-Heon Yoon, Eun Chang Choi, Seung Joon Baek, Growth inhibition and apoptosis by (−)-epicatechin gallate are mediated by cyclin D1 suppression in head and neck squamous carcinoma cells, European Journal of Cancer, 2006, 42, 18, 3260

    CrossRef

  54. 54
    C Mascaux, B Martin, M Paesmans, T Berghmans, M Dusart, A Haller, P Lothaire, A-P Meert, J-J Lafitte, J-P Sculier, Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results, British Journal of Cancer, 2006, 95, 2, 139

    CrossRef

  55. 55
    Konstantinos Vlachtsis, Angelos Nikolaou, Konstantinos Markou, George Fountzilas, Ioannis Daniilidis, Clinical and molecular prognostic factors in operable laryngeal cancer, European Archives of Oto-Rhino-Laryngology, 2005, 262, 11, 890

    CrossRef

  56. 56
    MICHAEL SPINK, SAUL BAHN, ROBERT GLICKMAN, Clinical implications of cyclo-oxygenase–2 inhibitors for acute dental pain management, The Journal of the American Dental Association, 2005, 136, 10, 1439

    CrossRef

  57. 57
    Uma Raju, Hisanori Ariga, Klaus Dittmann, Eiko Nakata, Kian K. Ang, Luka Milas, Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxib, International Journal of Radiation Oncology*Biology*Physics, 2005, 63, 2, 520

    CrossRef

  58. 58
    Giovanni Almadori, Francesco Bussu, Gabriella Cadoni, Jacopo Galli, Gaetano Paludetti, Maurizio Maurizi, Molecular markers in laryngeal squamous cell carcinoma: Towards an integrated clinicobiological approach, European Journal of Cancer, 2005, 41, 5, 683

    CrossRef

  59. 59
    Giovana R. Thomas, Hari Nadiminti, Jacinto Regalado, Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma, International Journal of Experimental Pathology, 2005, 86, 6
  60. 60
    Helmout Modjtahedi, Molecular therapy of head and neck cancer, Cancer and Metastasis Reviews, 2005, 24, 1, 129

    CrossRef

  61. 61
    Wade Smith, Nabil Saba, Retinoids as chemoprevention for head and neck cancer: where do we go from here?, Critical Reviews in Oncology/Hematology, 2005, 55, 2, 143

    CrossRef

  62. 62
    Madeleine A. Kane, The role of folates in squamous cell carcinoma of the head and neck, Cancer Detection and Prevention, 2005, 29, 1, 46

    CrossRef

  63. 63
    Michalis V Karamouzis, Athanasios G Papavassiliou, COX-2 inhibition in cancer therapeutics: a field of controversy or a magic bullet?, Expert Opinion on Investigational Drugs, 2004, 13, 4, 359

    CrossRef

  64. 64
    Pierre Giglio, Victor Levin, Cyclooxygenase-2 Inhibitors in Glioma Therapy, American Journal of Therapeutics, 2004, 11, 2, 141

    CrossRef

  65. 65
    John C Rhee, Fadlo R Khuri, Dong M Shin, Emerging drugs for head and neck cancer, Expert Opinion on Emerging Drugs, 2004, 9, 1, 91

    CrossRef

  66. 66
    Kyubo Kim, Hong-Gyun Wu, Suk Won Park, Chong Jai Kim, Charn Il Park, Expression of Cyclooxygenase (COX)-2 as a Prognostic Factor in Nasopharyngeal Cancer, Cancer Research and Treatment, 2004, 36, 3, 187

    CrossRef

  67. 67
    Shouwei Han, Neil Sidell, Susanne Roser-Page, Jesse Roman, Fibronectin stimulates human lung carcinoma cell growth by inducing cyclooxygenase-2 (COX-2) expression, International Journal of Cancer, 2004, 111, 3
  68. 68
    Ezra E.W. Cohen, Novel therapeutic targets in squamous cell carcinoma of the head and neck, Seminars in Oncology, 2004, 31, 6, 755

    CrossRef

  69. 69
    Sanjay Jain, Fadlo R. Khuri, Dong M. Shin, Prevention of head and neck cancer: Current status and future prospects, Current Problems in Cancer, 2004, 28, 5, 265

    CrossRef

  70. 70
    K. Yamamoto, W. Kitayama, A. Denda, A. Morisaki, H. Kuniyasu, M. Inoue, T. Kirita, Suppressive effects of a selective cyclooxygenase-2 inhibitor, etodolac, on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis, Experimental and Toxicologic Pathology, 2004, 56, 3, 145

    CrossRef

  71. 71
    Edward I. Cho, Diane P. Kowalski, Clarence T. Sasaki, Bruce G. Haffty, Tissue Microarray Analysis Reveals Prognostic Significance of COX-2 Expression for Local Relapse in T1–2N0 Larynx Cancer Treated with Primary Radiation Therapy, The Laryngoscope, 2004, 114, 11
  72. 72
    Sivani Mohan, Joel B. Epstein, Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer, Oral Oncology, 2003, 39, 6, 537

    CrossRef

  73. 73
    H. Nishihara, S. Kizaka-Kondoh, P. A. Insel, L. Eckmann, Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2, Proceedings of the National Academy of Sciences, 2003, 100, 15, 8921

    CrossRef

  74. 74
    Kazuhiko Yamamoto, Wakashi Kitayama, Ayumi Denda, Ayumu Morisaki, Hiroki Kuniyasu, Tadaaki Kirita, Inhibitory effects of selective cyclooxygenase-2 inhibitors, nimesulide and etodolac, on the development of squamous cell dysplasias and carcinomas of the tongue in rats initiated with 4-nitroquinoline 1-oxide, Cancer Letters, 2003, 199, 2, 121

    CrossRef

  75. 75
    Felicia L. Johnson, Management of advanced premalignant laryngeal lesions, Current Opinion in Otolaryngology & Head and Neck Surgery, 2003, 11, 6, 462

    CrossRef

  76. 76
    Lori J Wirth, Robert I Haddad, Marshall R Posner, Progress and perspectives in chemoprevention of head and neck cancer, Expert Review of Anticancer Therapy, 2003, 3, 3, 339

    CrossRef

  77. 77
    Juan J. Grau de Castro, Juan Jesús Cruz-Hernández, Quimioprevención del cáncer, Medicina Clínica, 2003, 121, 12, 457

    CrossRef

  78. 78
    David W Kim, Dean M Toriumi, What’s new in otolaryngology—head and neck surgery, Journal of the American College of Surgeons, 2003, 197, 1, 97

    CrossRef

  79. 79
    Asma A. Khan, Raymond A. Dionne, COX-2 inhibitors for endodontic pain, Endodontic Topics, 2002, 3, 1
  80. 80
    Eric R. Carlson, Daniel Oreadi, Ablative Oral/Head and Neck Surgery,